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reverse T3 (rT3) level indicate on altered thyroid hormone 
peripheral metabolism.
Conclusion Both the presence and the type of sweet flavour 
carrier have a significant impact on thyroid axis activity. 
Our findings suggest that this organochlorine sweetener is 
metabolically active and might exacerbate metabolic disor-
ders via an adverse effect on thyroid hormone metabolism.
Keywords Thyroid hormones · Sucrose · Non-nutritive 
sweeteners · Sucralose
Introduction
The adaptive evolutionary development resulted in a dis-
tinct preference for sweet-tasting foods as a desirable 
source of energy [1]. Facing the fact that an innate desire 
for sweetness has been linked to the global rising rates of 
obesity and comorbidities, non-nutritive sweeteners (NNS) 
have been proposed as a useful tool for both prevention and 
dietary interventions in the treatment of those diet-related 
disorders [2].
However, the impact of artificial sweeteners on human 
health raises a number of concerns [3, 4]. There is accu-
mulating evidence that the discrepancy between a sweet 
taste and the expected energy dose could have hormonal, 
metabolic, and thermogenic consequences [5]. Adverse 
effects of NNS consumption on the energy balance leading 
to hyperphagia and weight gain have been reported [6–9] 
although the mechanisms of their occurrence are not yet 
fully characterised [2, 9].
Despite the presumed effect of artificial sweeteners on 
the body energy balance, their impact on thyroid activ-
ity has not been investigated. Thyroid hormones (TH) 
play an essential role in maintaining energy homoeostasis 
Abstract 
Purpose Non-nutritive sweeteners are the most widely 
used food additives worldwide. However, their metabolic 
outcomes are still a matter of controversy and their effect 
on the thyroid activity, a key regulator of metabolism, has 
not been previously studied. Therefore, we aim to deter-
mine the influence of the sweet type flavour carrier on 
selected parameters of thyroid axis activity.
Methods Male Sprague–Dawley rats (n = 105) were 
divided into 3 groups fed ad libitum for three weeks isoca-
loric diets (3.76 ± 0.5 kcal/g): two with the same sweet fla-
vour intensity responded to 10% of sucrose (with sucrose–
SC—and sucralose—SU) and one non-sweet diet (NS). To 
evaluate the post-ingested effects, animals were euthanised 
at fast and 30, 60, 120, 180 min after meal.
Results The results obtained indicate that both the presence 
and the type of sweet taste flavour carrier affect thyroid 
axis activity both at fasting and postprandial state. Com-
pared to diet with sucrose which stimulates thyroid axis 
activity, sucralose addition diminishes thyroid hormone 
synthesis as thyroid peroxidase (TPO) activity, plasma thy-
roxine (T4), and triiodothyronine (T3) concentration was 
lower than in SC and NS while in non-sweet diet the lowest 
level of hepatic deiodinase type 1 (DIO1) and the highest 
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through both central and peripheral pathways [10]. They 
are involved in the regulation of protein, fat, and carbo-
hydrate metabolism; thus, both the quantity and quality of 
the diet affect hypothalamic-pituitary-thyroid (HPT) axis 
activity [11, 12]. Circulating levels of thyroid hormones 
are impacted by the consumption of carbohydrates [13, 14]. 
According to Shafrir [13], a sucrose-rich diet accelerated 
T4 to T3 conversion and induced the elevation of T3, while 
the deprivation of carbohydrates decreased plasma T3 con-
centration [14]. Early studies on the relationship between 
nutrition and thyroid function provided evidence that only 
diets containing carbohydrates were able to normalise the 
plasma thyroid hormone profile after long-term fasting 
[15].
Therefore, we aimed to compare the effects of isoca-
loric sweetness-matched diets with sucrose and sucralose 
on thyroid activity. Sucralose is a chlorinated disaccharide 
with the chemical formula 1,6-dichloro-1,6-dideoxy-β-D-
fructofuranosyl-4-chloro-4-deoxy-α-D-galactopyranoside. 
Sucralose is authorised in the European Union for food use; 
its safety has been extensively evaluated, and an acceptable 
daily intake (ADI) of 15 mg/kg of body weight was estab-
lished by the EU Scientific Committee on Food. Sucralose 
is approximately 600 times sweeter by weight than sucrose 
and, among commonly used NNS, the flavour profile of 
sucralose is the most similar to that of sucrose [16]. Due to 
its physicochemical properties, sucralose is found in thou-
sands of beverages, food, and pharmaceutical products as a 
sugar substitute [17].
In vitro studies have demonstrated that sucralose and 
sucrose stimulate the same sweet taste G protein-coupled 
receptor complex T1R2/T1R3 in the oral cavity of humans, 
pigs, rats, and mice [18]. Studies of absorption, distribu-
tion, and metabolism of sucralose suggest that the phar-
macokinetics of sucralose is similar in humans and rats, 
although the threshold of sweetness acceptance of sucra-
lose is different [19]. Over the past few years, the body of 
data on taste-related signalling molecules found in extraoral 
tissue has grown constantly [20, 21]. Sweet taste receptors 
are expressed in the gastrointestinal tract, pancreas, brain, 
and adipose tissue where they are presumed to be involved 
in nutrient-sensing and energy metabolism regulation [22]. 
Moreover, T1R2 and T1R3 are expressed in tissues wherein 
their function appears less evident, including those of blad-
der, heart, and testis [20, 21]. Sweet tastants might also 
exert an important regulatory role in thyroid axis activity 
since G protein-coupled bitter taste receptors were also 
found in the thyroid gland where they appear to mediate a 
protective response to endocrine disruptors by regulating 
thyrocyte function and hormone production [23].
The purpose of this study was to determine the effect 
of a sweet-tasting diet on selected parameters of thyroid 
axis activity including the concentration of the plasma 
thyroid-stimulating hormone (TSH), thyroxine, trii-
odothyronine, both total and free (T4, T3 and fT4, fT3, 
respectively), reverse triiodothyronine (rT3), as well as 
thyroid peroxidase (TPO) and hepatic deiodinase type 
1 (DIO1) content, using a rodent model. Three types 
of diets were tested: (1) a diet sweetened with a caloric 
sweetener—sucrose, (2) a diet sweetened with an artifi-




The experiment was carried out on 105 8-week-old male 
Sprague–Dawley rats with an average initial body weight 
of 325 ± 19 g obtained from the Medical Research Cen-
tre of the Polish Academy of Sciences (Warsaw, Poland).
Animals were individually housed under controlled 
environmental conditions (12-h light: 12-h darkness 
cycle, temperature 22 ± 1 °C, and 60% humidity) with 
ad libitum access to standard rodent chow (Labofeed H) 
and fresh water. After a 7-day adaptation period, animals 
(n = 105) were randomly assigned to three groups and for 
three weeks fed ad libitum semisynthetic (based on AIN-
93-M diet formula) isocaloric diets (3.76 ± 0.5 kcal/g): 
two with the same sweetness intensity equivalent to 10 g 
of sucrose per 100 g of food (with sucrose—SC—and 
sucralose—SU) and one non-sweet diet (NS). Diet com-
position is presented in Table 1.
Food intake was recorded daily and body weight 
three times per week. At the end of the experiment, ani-
mals were euthanised after 16-hour fast and 30, 60, 120, 
180 min after a meal corresponding to the examined 
group (7 rats from each group/time point). Blood was 
Table 1  Composition of experimental diets (g/100 g)
NS non-sweet diet, SC diet with sucrose, SU diet with sucralose
* Mineral and vitamin mixtures were provided by Sigma-Aldrich 
(USA)
Ingredients NS SC SU
Wheat starch 63.5 53.5 63.48
Sucrose 0 10 0
Sucralose 0 0 0.0167
Casein 20.0 20.0 20.0
Soybean oil 7.0 7.0 7.0
Potato starch 5.0 5.0 5.0
Mineral mixture* 3.5 3.5 3.5
Vitamin mixture 1.0 1.0 1.0
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collected by cardiac puncture. Thyroids and livers were 
taken out and immediately frozen in liquid nitrogen. 
Blood serum, thyroids, and livers were stored at −80 °C 
until further analysis. The study protocol was approved 
by the 3rd Local Ethical Commission in Warsaw (no. 
27/2009), and the study was conducted in compliance 
with applicable national laws and regulations.
Biochemical analysis
The concentrations of the plasma thyroid-stimulating hor-
mone (TSH), thyroxine, triiodothyronine, both total and 
free (T4, T3, and fT4, fT3, respectively), and reverse trii-
odothyronine (rT3) were measured by radioimmunoassay 
using commercial kits (IZOTOP, Institute of Isotopes 
Ltd., Budapest, Hungary). All procedures were carried out 
according to provided kit instructions. Hormone determina-
tions were made in triplicate. The sensitivity for TSH, T4, 
T3, fT4, fT3, and rT3 was 0.5 ng/ml, 7 nmol/l, 0.3 nmol/l, 
0.7 nmol/l, 0.58 pmol/l, 0.009 ng/ml, respectively.
Thyroid peroxidase (TPO) preparation and analysis were 
done using the method described by Hosoya et al. [24]. 
Enzyme activity from the thyroid microsomal fraction was 
determined spectrophotometrically at 350 nm by measur-
ing the rate of oxidation of iodide to iodine in the presence 
of hydrogen peroxide as a second substrate. The measure-
ment was performed at room temperature (21 ± 1 °C), and 
the absorbance was measured every 8 s for 160 s. The reac-
tion mixture contained the enzyme preparation (40–80 μg), 
phosphate buffer (50 mM, pH = 7.4), hydrogen peroxide 
(135 mM), and potassium iodide (13 mM). Protein concen-
tration was measured by the method of Bradford (Merck, 
Germany) with bovine serum albumin (BSA) as a standard 
(Sigma-Aldrich, USA). A TPO activity unit was defined as 
the change in the absorbance of 0.001 per second per 1 mg 
of protein in the enzyme preparation (mU/s/mg protein).
The level of deiodinase type 1 (DIO1) protein in liver 
homogenates was measured by the sandwich immunoassay 
method validated for use in rats (USCN Life Science Inc., 
China) according to the manufacturer’s instructions. The 
DIO1 level was expressed as ng per mg liver homogenate 
protein determined by the Bradford method with BSA as a 
standard (Sigma-Aldrich, USA). The minimum detectable 
dose of rat DIO1 was less than 0.065 ng/ml. No significant 
cross-reactivity or interference was observed with deiodi-
nase type 1.
Statistical analysis
Results are presented as mean ± SEM. Two-way ANOVA 
was used to analyse changes in food ingestion, body 
weight, and the effects of the diet and time, followed by the 
post hoc LSD Fisher’s test. Differences were considered to 
be significant at p < 0.05. All statistical analyses were per-
formed using the Statistica v10 software package (StatSoft, 
USA).
Results
Food intake and body weight gain
Both food intake and body mass gain were signifi-
cantly affected by the type of diet (for both p < 0.001). 
In total, the highest food intake was recorded in the SU 
group. The average daily intake of sucralose with the diet 
(14.2 ± 0.4 mg/kg body weight/day) did not exceed the 
acceptable daily intake (ADI, 15 mg/kg body weight/day).
The food intake recorded during the meal before eutha-
nasia did not differ between NS, SC, and SU, and was 
3.98 ± 0.5, 4.22 ± 0.41, and 4.71 ± 0.5, respectively.
The total daily body weight gain in the SU group was 
significantly higher than in SC and NS, which represented 
the lowest value (for both p < 0.001). Therefore, the highest 
diet growth efficiency was also recorded in SU, and there 
were no differences between NS and SC (Table 2).
Table 2  Food intake, body 
weight, and thyroid mass to 
body weight index across 
dietary groups
Data presented as mean ± SEM
NS non-sweet diet, SC diet with sucrose, SU diet with sucralose
* Diet growth efficiency—body weight gain (g/day) to food intake (g/day) ratio
A, B, C letters indicate significant differences between dietary groups (p < 0.05)
Monitored parameters Dietary groups
NS SC SU
Food intake (g/day) 25.01 ± 0.26A 29.15 ± 0.16B 31.18 ± 0.26C
Body weight gain (g/day) 1.58 ± 0.06A 2.00 ± 0.05B 2.58 ± 0.05C
Diet growth efficiency (g/day)* 0.06 ± 0.003A 0.07 ± 0.002A 0.09 ± 0.002B
Thyroid/body weight (mg/100 g body weight) 5.22 ± 0.43 5.79 ± 0.36 6.21 ± 0.33
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The thyroid to body weight index did not differ among 
the groups (Table 2).
TSH, TPO activity, and plasma thyroid hormone 
concentrations
The plasma TSH level was significantly influenced by 
the diet type (p < 0.001) as shown in Fig. 1. The interac-
tions between the diet type and time after meal ingestion 
were also shown (p = 0.002). At fasting, TSH concentra-
tion in the SU group was significantly lower than in the 
two other groups (for both p < 0.001). Food intake did not 
affect TSH concentrations in NS, while postprandial TSH 
changes in SC were different from those observed in SU. 
After 180 min, a 30% decrease in SC and the same degree 
of TSH increase in SU were noted (180 min vs baseline, 
p < 0.001 and p = 0.014, respectively) (Fig. 1).
TPO activity was significantly influenced by the type 
of diet (p < 0.001) and time after the meal (p < 0.001). At 
fasting, TPO activity was significantly lower in SU than in 
the SC and NS groups (for both p < 0.001). Food ingestion 
caused an increase in TPO activity only in the sweet-tasting 
diets observed at different time points—after 30 min in SU 
(30 min vs baseline, p = 0.004) and after 180 min in SC 
(180 min vs baseline, p = 0.033). In SC, TPO activity at 
the end of the sampling period remained higher than the 
values in SU and NS (for both p < 0.001) (Fig. 2).
For T4 concentration, the effects of the diet type 
(p < 0.001) and time after the meal (p < 0.001) as well 
as the interaction between both factors (p < 0.001) were 
significant. The triiodothyronine level was affected 
solely by the diet type (p < 0.001). At fast, T4 and T3 in 
SC were higher than in NS (p = 0.033 and p = 0.021, 
respectively) and SU (for both p < 0.001). Postprandial 
T4 changes were observed only in the SC group where 
the T4 level decreased significantly 180 min after the 
meal (180 min vs baseline p = 0.015). During the entire 
sampling period, T4 levels in SU were lower than in NS 
and SC (for both p < 0.001). There were no significant 
postprandial alterations in T3 concentration in the exper-
imental groups, and in SU the hormone level remained 
significantly lower than in NS and SC at each time point 
(for all p < 0.05) (Fig. 3a, c).
Baseline fT4 levels did not differ among the groups. 
Food intake affected the fT4 level in the groups receiv-
ing the sweetened diets, but the pattern differed between 
those groups. In SU, a significant increase occurred 
30 min after the meal (30 min vs baseline p = 0.031), 
while in SC, an evident decrease was observed after 
180 min (180 min vs baseline p = 0.025). At the end 
point, fT4 levels in SC and SU were lower than in NS 
(p = 0.043 and p = 0.035, respectively) (Fig. 3b).
The fasting fT3 plasma level in SU was higher than in 
the other groups (for both p < 0.001). The feeding caused 
a significant increase in fT3 concentration in the groups 
fed sweetened diets. In SC, the increase occurred after 
30 min (p = 0.002), and in SU it was observed 30 min 
later (p = 0.027). At the end of the sampling period, the 
fT3 level in SU remained higher than in the two other 
groups (for SC p = 0.040, for NS p = 0.018) (Fig. 3d). 
There were no significant post meal changes in fT3 con-
centration in rats fed the non-sweet diet; however, after 
180 min, the hormone level was not different from the SC 
value
Both at fasting and postprandially, fT4/T4 and fT3/
T3 in SU were significantly higher than in NS and SC 
(p < 0.05 for all) (Fig. 4a, b). At fast and at the end point, 
the T3/T4 ratio remained significantly higher in SU than 
in NS (p = 0.017), but not different from the ratio noted 
in SC (Fig. 4c).
At fasting, rT3 concentration in NS was higher than in SC 
and SU (for both p < 0.001) and despite a feeding-induced 
decline remained the highest after 180 min (p = 0.038 and 
p = 0.045, respectively). There were no postprandial changes 
in rT3 in the groups fed the sweetened diets (Fig. 4d).
Fig. 1  Plasma TSH concentration (ng/ml) at fasting, 30, 60, 120, 
180 min after the meal; NS non-sweet diet, SC diet with sucrose, SU 
diet with sucralose; data presented as mean ± SEM; *p < 0.05 com-
pared to baseline
Fig. 2  TPO activity (mU/s/mg protein) at fasting and 30, 60, 120, 
180 min after the meal; NS, non-sweet diet; SC, diet with sucrose; 
SU, diet with sucralose; data presented as mean ± SEM; *p < 0.05 
compared to baseline
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Fig. 3  Plasma thyroid hormone concentration at fasting and 30, 
60, 120, 180 min after the meal; NS, non-sweet diet; SC, diet with 
sucrose; SU, diet with sucralose; a thyroxine concentration (nmol/l); 
b free thyroxine concentration (pmol/l); c triiodothyronine concentra-
tion (nmol/l); d free triiodothyronine concentration (pmol/l); data pre-
sented as mean ± SEM; *p < 0.05 compared to baseline
Fig. 4  a fT4/T4 index; b fT3/T3 index; c T3/T4 index; d rT3 (ng/ml) at fasting and 30, 60, 120, 180 min after the meal; NS, non-sweet diet; SC, 
diet with sucrose; SU, diet with sucralose; data presented as mean ± SEM; *p < 0.05 compared to baseline
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Deiodinase type 1 level in the liver
At fasting, the hepatic DIO1 level in NS was lower than 
in SC and SU (p = 0.011 and p < 0.001, respectively). 
Although the meal did not evoke any significant changes in 
the level of the hepatic enzyme, postprandial DIO1 in SU 
was significantly higher compared to NS (p < 0.001) and 
SC (p < 0.001) (Fig. 5).
Independently from the sampling period, a positive cor-
relation between TSH concentration and T4 (r = 0.45, 
p = 0.035) was determined in SC only.
Discussion
The hypothalamic-pituitary-thyroid axis response to altera-
tions in the quantity and quality of the diet plays an essen-
tial role in the metabolic adaptation to ingested nutrients 
[25]. Carbohydrates have been shown to affect thyroid 
axis activity [13]; however, the effect of their non-nutritive 
substitutes on thyroid parameters remained as yet uninves-
tigated. In our study, three isoenergetic diets with equal lev-
els of carbohydrates were applied: two with the addition of 
sweetness-matched sucrose and sucralose and the third one 
without a sweet flavour carrier.
The data on food intake, body weight gain, and diet effi-
ciency presented in this study were previously discussed [26].
We have shown that both the presence of a sweet fla-
vour and the type of its carrier affect thyroid axis activity 
at fast and postprandial state. As baseline TPO activity, 
TSH, T4, and T3 concentrations did not differ signifi-
cantly in rats fed the non-sweet diet and in rats receiv-
ing the diet with sucrose, the effect of the sweet taste on 
those parameters may be excluded. Hence, lower levels 
of those indices in SU should be exclusively attributed 
to the presence of sucralose in the diet. Lower basal 
TSH followed by reduced TPO activity and plasma thy-
roid hormone levels might indicate a decreased central 
or peripheral feedback control and resembles the rela-
tions in HPT axis activity during starvation [27] or in 
the non-thyroidal illness syndrome [28]. It is noteworthy 
that lower levels of TSH and total thyroid hormones in 
the SU group occurred despite a higher daily food intake 
and weight gain than in the two other groups. This is 
inconsistent with the known positive relations between 
the amount of consumed food and the levels of circulat-
ing thyroid hormone [29] and might suggest that regular 
exposure to sucralose alters the thyroid axis response to 
ingested food.
Interestingly, lower levels of total T4 and T3 were 
accompanied by higher free-to-total thyroid hormone ratios 
in the group on the sucralose-added diet than in NS and 
SC. Although at fast, fT4 concentration was not influenced 
by the diet type, fT3 in SU remained at the highest level. 
Taking into consideration that free fatty acids (FFA) com-
pete with T4 and T3 for binding sites on plasma transport 
proteins [30], a higher free-to-total hormone concentration 
ratio in SU might have resulted from a substantially higher 
postprandial lipaemia than in the two other groups.
On the other hand, the pattern of HPT axis compo-
nents—decreased TPO activity, TSH, T4, and T3 plasma 
concentrations together with increased free-to-total TH 
ratios in the group on the diet with sucralose—resembles 
some effects evoked by organochlorine compounds docu-
mented in human and animal studies. The inverse relation-
ships between plasma levels of chloroorganic compounds 
and TSH or the thyroid hormone have been observed 
[31–35]. The association between high levels of fT4 and 
the consumption of fish exposed to organochlorinated 
xenobiotics was found in adults from a certain area in East 
Slovakia [36]. This could be explained by the binding of 
chloroorganic compounds residues to transthyretin [37]. In 
the light of these parallels, our results could raise questions 
about the physiological inertness of sucralose.
Such doubts were already expressed by others on the 
basis of the influence of sucralose intake on the expres-
sion of rat intestinal P-glycoprotein (P-gp) and cytochrome 
P-450 isozymes, which are key components of the detoxi-
fication system in first-pass drug metabolism [38]. Altera-
tions in beneficial intestinal microflora and epithelial bor-
der function after long-term sucralose ingestion were also 
recorded [38, 39]. However, in two-year carcinogenicity 
studies administration of sucralose in high doses was not 
connected with any sucralose-related neoplasms includ-
ing thyroid tumours [40, 41]. Even though plasma thy-
roid profile was not included in those protocols, we could 
only assume that potential long-term deviations in thy-
roid axis activity would have been reflected in thyroid 
histopathology.
Fig. 5  Deiodinase type 1 level in the liver (ng/mg protein) at fast-
ing and 180 min after the meal; NS, non-sweet diet; SC, diet with 
sucrose; SU, diet with sucralose; A, B, C letters indicate significant 
differences between dietary groups (p < 0.05); data presented as 
mean ± SEM; *p < 0.05 compared to baseline
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After the food was consumed, changes in the monitored 
parameters occurred only in the groups fed the sweetened 
diets and their postprandial time course of changes was 
affected by the type of sweet flavour carrier. Two contrary 
trends in TSH concentration might indicate distinct post-
ingestion regulatory mechanisms. The meal-induced TSH 
decline observed in the sucrose-fed group was reported 
also by others [42–44]. Recently, the role of bile acids in 
the postprandial TSH decrease has been suggested [42]. 
The high expression of the bile acid receptor TGR-5 was 
found in the paraventricular and supraoptic nuclei of the 
hypothalamus in rats [45]. This might indicate that bile 
acid–TGR-5 signalling regulates thyroid axis activity by a 
direct modulation of TRH and TSH release. However, in 
our study the same fat content and fatty acid composition, 
lower daily food and, consequently, fat intake in SC com-
pared to SU eliminate the impact of bile acids on the differ-
entiation of TSH response to meal intake. Therefore, we are 
likely to presume that a more efficient negative feedback 
mechanism was involved in the post-ingestive TSH decline 
in SC as the postprandial T3 concentration in animals on 
the diet with sucrose was markedly higher than in SU.
Distinct neuronal [46–48] and hormonal [49, 50] reac-
tions after sucrose and sucralose intake should also be 
taken into account. Although sweet taste perception of 
both these tastants is mediated by heterodimeric T1R2 and 
T1R3 gustducin-coupled receptors present in the oral cav-
ity, sucralose binds to taste receptor subunits with greater 
affinity than sucrose [51]. This finding might have a pro-
found metabolic implication since sweet taste receptors 
have also been identified in the brain, pancreas, and gas-
trointestinal tract [20, 21]. It is worth pointing out that taste 
genes are highly expressed in paraventricular nuclei of the 
hypothalamus—a brain region fundamentally implicated 
in thyroid hormone feedback regulation [52]. The higher 
expression level of the Tas1r2 gene in cultured hypothala-
mus cells exposed to a hypoglycaemic medium and the 
lower transcript level observed after the exposition to a 
higher concentration of glucose indicate that the taste sig-
nalling mechanism in the brain is regulated by a nutritional 
status and could be involved in the central control of energy 
homoeostasis. Interestingly, the addition of sucralose into 
a low-glucose medium elicited a greater Tas1r2 expres-
sion decline than hyperglycaemic conditions, indicating 
that the taste-like signalling in hypothalamic neurons does 
not require an intracellular increase in glucose metabolism 
[52]. Therefore, it was suggested that the stimulation of 
taste receptors in nutrient-sensing brain areas by artificial 
sweeteners might impair the central mechanism regulating 
glucose metabolism [52].
Furthermore, it has been established that sucrose and 
sucralose impact differently the reward system—dopa-
minergic midbrain areas that play an essential role in 
motivated behaviour. Frank et al. [47] demonstrated, using 
functional magnetic resonance imaging, that although 
both 10% sucrose and an equisweet sucralose solution 
activated neuronal taste pathways, sucrose more strongly 
induced the reward-related regions of the brain. Moreover, 
sucrose, but not sucralose, was able to induce dopamine 
release in mice lacking functional sweet taste transduc-
tion (trmp5−/−), which suggests that the dopamine-related 
brain reward system responds to metabolic signals rather 
than gustatory inputs [46] and the glucose oxidation rate 
independently of sweetness perception plays a key role in 
dopamine release [48]. This indicates that the reward sys-
tem acts as a metabolic sensor regulating sugar-specific 
behavioural preferences. Thus, the diet with added sucrose 
and probably a higher glucose oxidation rate than the diet 
with starch accompanied with non-metabolisable sucralose 
might influence thyroid axis activity through the modula-
tion of brain dopamine circuits as it is known that dopa-
mine administration suppresses TSH release [53].
Besides glucose-containing sugars that have a dominant 
role in dopamine release in a concentration-dependent man-
ner [54], midbrain dopamine neurons express insulin [55], 
leptin [56], and glucagon-like peptide 1 (GLP-1) recep-
tors [57]. The secretion of gut hormones including GLP-1, 
glucose-dependent insulinotropic peptide (GIP), cholecys-
tokinin (CCK), and peptide YY (PYY) is induced by the 
sweet taste receptor heterodimer T1R2/T1R3 expressed in 
intestinal enteroendocrine cells in response to the presence 
of tastants in the lumen [58, 59]. Although in vitro studies 
conducted on the human L cell line NCI-H716 have shown 
that both sucrose and sucralose stimulate GIP and GLP-1 
secretion [60], in clinical trials oral [49] and intragas-
tric infusion [50, 61] of sucralose solutions did not affect 
insulin, GLP-1, and PYY secretion. In our study, the insu-
lin level was found to be lower in the group fed the diet 
with sucralose than sucrose despite the fact that both were 
accompanied by starch [26]. Hence, those observations pro-
vide indirect evidence of a lower GLP-1 level in SU which 
is responsible for approximately 50–70% of postprandial 
plasma insulin increase [50]. Since GLP-1 [62] and peptide 
YY [63] were shown to modulate TSH secretion, various 
effects of sucrose and sucralose on incretins release could 
contribute to the observed differences in the TSH response 
to a meal.
Similarly, as in the case of TSH, meal ingestion evoked 
TPO activity changes only in animals fed the sweetened 
diets. In both SC and SU, increases in postprandial TPO 
activity were recorded; however, the peak times were dif-
ferent. This rapid growth of TPO activity in rats fed the 
sucralose-added diet might result from post-translational 
modifications combined with a movement to the follicular 
cell apical membrane and the formation of a multiprotein 
complex involved in thyroid hormone biosynthesis [64]. 
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However, striking is the fact that TPO activity increase in 
SU was accompanied by the lowest T4 level during the 
entire sampling period.
Despite the known species derived differences in thy-
roid economy between humans and rodents [65, 66], it was 
demonstrated that total T4 levels in rodents are a valid indi-
cator of thyroid function in relation to effects in humans 
[67]. Moreover, humans and rats might be equally sensi-
tive to TH synthesis disruptors, and even though in rats 
the response occurs after a shorter exposure time, the final 
effect could be the same [68].
The changes in TPO activity in both groups in the moni-
tored time points are difficult to link with the changes in 
the TSH plasma concentration. We presume the impact of 
other factors on thyroid activity including insulin, insulin-
like growth factor-1 (IGF-1) [69], norepinephrine, acetyl-
choline, and peptides—neuropeptide Y (NPY), vasoac-
tive intestinal peptide (VIP), substance P, CCK, or gastrin 
[70]. Interestingly, it was recently shown that bitter taste 
receptors are also expressed in thyrocytes. They negatively 
regulate TSH-dependent Ca2+ signalling, TSH-dependent 
iodide efflux, TPO activity, and TH production. Therefore, 
it is suggested that receptors activated by bitter-tasting 
stimuli might be involved in the protective response to an 
overdose of toxic substances [23]. Up to date, there have 
been no available data on the relationship between sweet 
taste receptors and the thyroid function.
The hepatic DIO1 level seemed to be increased by a 
sweet taste as liver enzyme content was lower and the 
rT3 plasma concentration was higher in rats fed the non-
sweet diet. The lower T3/T4 ratio and the DIO1 level in the 
liver of rats fed the non-sweetened diet suggest a reduced 
5′-monodeiodination efficiency. Since glucose and sucrose 
have been shown to stimulate DIO1 activity [13, 71], it is 
tempting to imply the role of extraoral sweet taste receptors 
in these effects.
Although the postprandial increase in the enzyme pro-
tein level was observed only in rats on the sucralose-added 
diet, the higher T3 baseline concentration and the post-
meal T4 decrease in SC suggest greater hepatic 5′-deiodi-
nation efficiency which presumably was caused by higher 
enzyme activity. Consequently, these observations support 
the previously demonstrated stimulatory effect of sucrose 
on hepatic T4 to T3 conversion [13, 72].
In summary, the sweet taste and its flavour carrier have 
a significant impact on pituitary-thyroid axis activity both 
at fast and postprandially. We showed that the effects pro-
moted by the non-sweet diet are different from those of the 
sweetened diet, wherein the diets with sucrose and sucra-
lose elicit opposite responses. In NS, the lowest hepatic 
DIO1 level and the highest rT3 at fasting and after feed-
ing indicated diminished metabolism of the peripheral thy-
roid hormone. Given the TPO activity, hepatic DIO1 level, 
and TH profile, it could be concluded that the addition of 
sucrose accelerates thyroid axis activity. In turn, a daily 
intake of sucralose with the diet at doses close to the rec-
ommended ADI might disrupt thyroid hormone synthesis 
as TPO activity, T4, and T3 plasma concentrations in rats 
demonstrated the lowest levels.
Conclusion
One principal finding of this study concerns the close rela-
tionship between the sweet flavour carrier and the pitu-
itary-thyroid axis activity, which is involved in the meta-
bolic adaptation to meal composition. This effect may be 
observed at various levels. Sucralose intake seems to 
diminish thyroid axis activity by decreasing TPO activity, 
TSH, and plasma total TH concentrations, but at the same 
time, it increases both free T3 and T4 indexes. Those find-
ings confirmed that sucralose is physiologically active and 
may provoke disturbances in thyroid axis activity. Aware of 
uncertainties in the interpretation and extrapolation of data 
from laboratory animals to humans, we acknowledge that 
further studies are required to support these findings.
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